REVVITY INC (RVTY)

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation

RVTY Crosses Below Key Moving Average Level

RSI Alert: Revvity (RVTY) Now Oversold

Top S&P500 movers in Monday's pre-market session

These S&P500 stocks are moving in today's pre-market session

Which S&P500 stocks have an unusual volume on Monday?

Which S&P500 stocks have an unusual volume on Monday?

Revvity Announces Financial Results for the Third Quarter of 2024

Revvity Board Declares Quarterly Dividend

Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories

Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report

Wednesday Sector Laggards: Healthcare, Technology & Communications

S&P 500 Movers: ULTA, UAL

Revvity To Hold Earnings Call on Monday, November 4, 2024

Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene

Alliant Energy Now #420 Largest Company, Surpassing Revvity

Commit To Buy Revvity At $115, Earn 11.3% Annualized Using Options

Revvity to Present at Upcoming Investor Conferences

Monday Sector Leaders: Services, Healthcare

RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q2 2024

RVTY stock results show that Revvity beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

S&P 500 Movers: ABT, ON

Revvity Announces Financial Results for the Second Quarter of 2024

Revvity Board Declares Quarterly Dividend

Revvity To Hold Earnings Call on Monday, July 29, 2024

Revvity to Present at Goldman Sachs Global Healthcare Conference

Commit To Buy Revvity At $105, Earn 10% Annualized Using Options

RVTY Makes Bullish Cross Above Critical Moving Average

RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q1 2024

RVTY stock results show that Revvity beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Revvity Announces Financial Results for the First Quarter of 2024

Revvity Board Declares Quarterly Dividend

Revvity to Present at BofA Securities 2024 Health Care Conference

Revvity Unveils a New Era of Automated Tuberculosis Testing

Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners